Table 3.
Molecular docking Studies on the CYP51 active site
| Compound | Binding Energy (Kcal/mol) * |
|---|---|
| D9 | -8.04 |
| D10 | -7.59 |
| D13 | -8.86 |
| Fluconazol | -6.47 |
*All the docking protocols were performed on validated structures with RMSD
values below 2 Å.
Molecular docking Studies on the CYP51 active site
| Compound | Binding Energy (Kcal/mol) * |
|---|---|
| D9 | -8.04 |
| D10 | -7.59 |
| D13 | -8.86 |
| Fluconazol | -6.47 |
*All the docking protocols were performed on validated structures with RMSD
values below 2 Å.